Publication: 199

Phase II trial of paclitaxel-topotecan-etoposide followed by consolidation chemoradiotherapy for limited-stage small cell lung cancer: CALGB 30002.
      Google Scholar   
Citation:
J Thorac Oncol vol 2 (7) 645-51
Year:
2007
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
798  
Children:
None
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
 
Grants:
CA31946, CA33601  
Corr. Author:
 
Authors:
                 
Networks:
 
Study
CALGB-30002
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Small Cell, Combined Modality Therapy, Dose-Response Relationship, Drug, Etoposide, Female, Follow-Up Studies, Humans, Lung Neoplasms, Male, Middle Aged, Paclitaxel, Retrospective Studies, Severity of Illness Index, Survival Rate, Topotecan, Treatment Outcome